A laser microdissection-based workflow for FFPE tissue microproteomics: Important considerations for small sample processing

Methods

Volumn 104, Issue , 2016, Pages 154-162

  Longuespée, Rémi ^a,b   Alberts, Deborah ^a   Pottier, Charles ^a,c   Smargiasso, Nicolas ^a   Mazzucchelli, Gabriel ^a   Baiwir, Dominique ^a   Kriegsmann, Mark ^d   Herfs, Michael ^a,c   Kriegsmann, Jörg ^b,e   Delvenne, Philippe ^a,c   De Pauw, Edwin ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b PROTEOPATH GMBH   (Germany)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e Institute for Histology Cytology and Molecular Diagnostics   (Germany)

Author keywords

Biomarkers; Cancer; Formalin fixed paraffin embedded; Laser microdissection; Mass spectrometry; Proteomics

Indexed keywords

BIOLOGICAL MARKER; CITRIC ACID; ANTIGEN; FORMALDEHYDE; PARAFFIN; PROTEIN;

ANTIGEN RETRIEVAL; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CYTOARCHITECTURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CANCER; LASER MICRODISSECTION; LIQUID CHROMATOGRAPHY; LIVER CANCER; LUNG CANCER; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SAMPLE SIZE; TANDEM MASS SPECTROMETRY; TISSUE SECTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR BIOPSY; UTERINE CERVIX CANCER; WORKFLOW; CHEMISTRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LASER; MICRODISSECTION; PROCEDURES; TISSUE FIXATION;

ANTIGENS; CHROMATOGRAPHY, LIQUID; CITRIC ACID; FORMALDEHYDE; HUMANS; LASERS; MICRODISSECTION; PARAFFIN EMBEDDING; PROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TISSUE FIXATION;

EID: 84954305170     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2015.12.008     Document Type: Article

References (42)

1. [1] Longuespee, R., Fleron, M., Pottier, C., Quesada-Calvo, F., Meuwis, M.A., Baiwir, D., Smargiasso, N., Mazzucchelli, G., De Pauw-Gillet, M.C., Delvenne, P., De Pauw, E., Omics: J. Integr. Biol. 18 (2014), 539–552.
2. [2] Magdeldin, S., Yamamoto, T., Proteomics 12 (2012), 1045–1058.
3. [3] Xu, B.J., Proteomics Clin. Appl. 4 (2010), 116–123.
4. [4] Wisniewski, J.R., Ostasiewicz, P., Mann, M., J. Proteome Res. 10 (2011), 3040–3049.
5. [5] Shi, S.R., Key, M.E., Kalra, K.L., J. Histochem. Cytochem. 39 (1991), 741–748.
6. [6] Fraenkel-Conrat, H., Olcott, H.S., J. Am. Chem. Soc. 68 (1946), 34–37.
7. [7] Fraenkel-Conrat, H., Olcott, H.S., J. Am. Chem. Soc. 70 (1948), 2673–2684.
8. [8] Shi, S.R., Imam, S.A., Young, L., Cote, R.J., Taylor, C.R., J. Histochem. Cytochem. 43 (1995), 193–201.
9. [9] Quesada-Calvo, F., Bertrand, V., Longuespee, R., Delga, A., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Delvenne, P., Malaise, M., De Pauw-Gillet, M.C., De Pauw, E., Louis, E., Meuwis, M.A., J. Proteomics 112 (2015), 250–261.
10. [10] Groseclose, M.R., Massion, P.P., Chaurand, P., Caprioli, R.M., Proteomics 8 (2008), 3715–3724.
11. [11] Gustafsson, J.O., Oehler, M.K., McColl, S.R., Hoffmann, P., J. Proteome Res. 9 (2010), 4315–4328.
12. [12] Longuespee, R., Gagnon, H., Boyon, C., Strupat, K., Dauly, C., Kerdraon, O., Ighodaro, A., Desmons, A., Dupuis, J., Wisztorski, M., Vinatier, D., Fournier, I., Day, R., Salzet, M., Proteomics Clin. Appl. 7 (2013), 337–354.
13. [13] Kriegsmann, M., Endris, V., Wolf, T., Pfarr, N., Stenzinger, A., Loibl, S., Denkert, C., Schneeweiss, A., Budczies, J., Sinn, P., Weichert, W., Oncotarget 5 (2014), 9952–9965.
14. [14] Foulkes, W.D., Smith, I.E., Reis-Filho, J.S., N. Engl. J. Med. 363 (2010), 1938–1948.
15. [15] Ignatiadis, M., Buyse, M., Sotiriou, C., Ann. Oncol. 26 (2015), 1519–1520.
16. [16] de Deus Moura, R., Wludarski, S.C., Carvalho, F.M., Bacchi, C.E., Appl. Immunohistochem. Mol. Morphol. 21 (2013), 1–12.
17. [17] Korhonen, T., Kuukasjarvi, T., Huhtala, H., Alarmo, E.L., Holli, K., Kallioniemi, A., Pylkkanen, L., Breast 22 (2013), 1119–1124.
18. [18] Petrelli, F., Barni, S., Breast Cancer Res. Treat. 142 (2013), 227–235.
19. [19] Pottier, C., Wheatherspoon, A., Roncarati, P., Longuespee, R., Herfs, M., Duray, A., Delvenne, P., Quatresooz, P., Expert Rev. Anticancer Ther. 15 (2015), 943–954.
20. [20] Engels, C.C., Fontein, D.B., Kuppen, P.J., de Kruijf, E.M., Smit, V.T., Nortier, J.W., Liefers, G.J., van de Velde, C.J., Bastiaannet, E., Br. J. Cancer 111 (2014), 532–538.
21. [21] Cox, J., Hein, M.Y., Luber, C.A., Paron, I., Nagaraj, N., Mann, M., Mol. Cell. Proteomics: MCP 13 (2014), 2513–2526.
22. [22] Kaemmerer, D., Peter, L., Lupp, A., Schulz, S., Sanger, J., Baum, R.P., Prasad, V., Hommann, M., Int. J. Clin. Exp. Pathol. 5 (2012), 187–194.
23. [23] Maree, R., Stevens, B., Rollus, L., Rocks, N., Lopez, X., Salmon, I., Cataldo, D., Wehenkel, L., Diagn. Pathol., 8, 2013, S26.
24. [24] Xu, H., Yang, L., Wang, W., Shi, S.R., Liu, C., Liu, Y., Fang, X., Taylor, C.R., Lee, C.S., Balgley, B.M., J. Proteome Res. 7 (2008), 1098–1108.
25. [25] Gustafsson, O.J., Eddes, J.S., Meding, S., McColl, S.R., Oehler, M.K., Hoffmann, P., Rapid Commun. Mass Spectrom. 27 (2013), 655–670.
26. [26] Kelstrup, C.D., Young, C., Lavallee, R., Nielsen, M.L., Olsen, J.V., J. Proteome Res. 11 (2012), 3487–3497.
27. [27] Liu, N.Q., Braakman, R.B., Stingl, C., Luider, T.M., Martens, J.W., Foekens, J.A., Umar, A., J. Mammary Gland Biol. Neoplasia 17 (2012), 155–164.
28. [28] Li, W., Zhai, B., Zhi, H., Li, Y., Jia, L., Ding, C., Zhang, B., You, W., Tumour Biol.: J. Int. Soc. Oncodevelopmental Biol. Med. 35 (2014), 8883–8891.
29. [29] Antony, M.L., Lee, J., Hahm, E.R., Kim, S.H., Marcus, A.I., Kumari, V., Ji, X., Yang, Z., Vowell, C.L., Wipf, P., Uechi, G.T., Yates, N.A., Romero, G., Sarkar, S.N., Singh, S.V., J. Biol. Chem. 289 (2014), 1852–1865.
30. [30] Papetti, M., Herman, I.M., Am. J. Pathol. 159 (2001), 165–178.
31. [31] Fan, J., Teng, X., Liu, L., Mattaini, K.R., Looper, R.E., Vander Heiden, M.G., Rabinowitz, J.D., ACS Chem. Biol. 10 (2015), 510–516.
32. [32] Locasale, J.W., Grassian, A.R., Melman, T., Lyssiotis, C.A., Mattaini, K.R., Bass, A.J., Heffron, G., Metallo, C.M., Muranen, T., Sharfi, H., Sasaki, A.T., Anastasiou, D., Mullarky, E., Vokes, N.I., Sasaki, M., Beroukhim, R., Stephanopoulos, G., Ligon, A.H., Meyerson, M., Richardson, A.L., Chin, L., Wagner, G., Asara, J.M., Brugge, J.S., Cantley, L.C., Vander Heiden, M.G., Nat. Genet. 43 (2011), 869–874.
33. [33] Pestalozzi, B.C., Zahrieh, D., Mallon, E., Gusterson, B.A., Price, K.N., Gelber, R.D., Holmberg, S.B., Lindtner, J., Snyder, R., Thurlimann, B., Murray, E., Viale, G., Castiglione-Gertsch, M., Coates, A.S., Goldhirsch, A., Int. Breast Cancer Study J. Clin. Oncol. 26 (2008), 3006–3014.
34. [34] Nagaraj, N., D'Souza, R.C., Cox, J., Olsen, J.V., Mann, M., J. Proteome Res. 9 (2010), 6786–6794.
35. [35] Stevenson, R.P., Veltman, D., Machesky, L.M., J. Cell Sci. 125 (2012), 1073–1079.
36. [36] Moscicki, A.B., Burt, V.G., Kanowitz, S., Darragh, T., Shiboski, S., Cancer 85 (1999), 1139–1144.
37. [37] Loureiro, J., Oliva, E., Arch. Pathol. Lab. Med. 138 (2014), 453–483.
38. [38] Martin, C.M., O'Leary, J.J., Best Practice Res. Clin. Obstetrics Gynaecol. 25 (2011), 605–615.
39. [39] Kobayashi, K., Ogata, H., Morikawa, M., Iijima, S., Harada, N., Yoshida, T., Brown, W.R., Inoue, N., Hamada, Y., Ishii, H., Watanabe, M., Hibi, T., Gut 51 (2002), 169–176.
40. [40] Gazi, M.H., He, M., Cheville, J.C., Young, C.Y., Cancer Biol. Ther. 7 (2008), 70–75.
41. [41] Longuespee, R., Boyon, C., Desmons, A., Vinatier, D., Leblanc, E., Farre, I., Wisztorski, M., Ly, K., D'Anjou, F., Day, R., Fournier, I., Salzet, M., Cancer Metastasis Rev. 31 (2012), 713–732.
42. [42] Balluff, B., Frese, C.K., Maier, S.K., Schone, C., Kuster, B., Schmitt, M., Aubele, M., Hofler, H., Deelder, A.M., Heck, A.J., Hogendoorn, P.C., Morreau, J., Maarten Altelaar, A., Walch, A., McDonnell, L.A., J. Pathol. 235 (2015), 3–13.